Medtronic Product Surveillance Registry

To provide continuing evaluation and periodic reporting of safety and effectiveness of market-released Medtronic products for their intended use.

(To collect information over time about how post-market Medtronic products are working and/or the outcome of the treatment.)

Inclusion Criteria

• Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements
• Patient has, or is intended to receive or be treated with, an eligible Medtronic product
• Patient is consented within the enrollment window of the therapy received, as applicable
• Additional criteria may be required, refer to Condition/Therapy Appendix for further guidance.

Exclusion Criteria

• Patient who is, or is expected to be, inaccessible for follow-up
• Patient is excluded by local law
• Patient is currently enrolled in, or plans to enroll in, any concurrent drug/device study that may confound the PSR results (i.e. no required intervention that could affect interpretation of all around product safety and/or effectiveness)

Additional criteria may be required, refer to Condition/Therapy Appendix for further guidance.